Cybin Stock (NASDAQ:HELP)
Previous Close
$7.44
52W Range
$4.81 - $10.72
50D Avg
$6.65
200D Avg
$6.94
Market Cap
$363.14M
Avg Vol (3M)
$877.19K
Beta
0.79
Div Yield
-
HELP Company Profile
Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder